Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
Introduction: Cutaneous immune-related adverse-events (cIRAEs), commonly seen in cancer patients receiving immune checkpoint inhibitors (ICI) are reported to be associated with better patient survival; however, they have seldom been studied in Indian population. Recent reports suggest racial differe...
Main Authors: | Prasanna Duraisamy, Vinitha Panicker, Wesley Jose |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2023-07-01
|
Series: | Dermatology Practical & Conceptual |
Subjects: | |
Online Access: | http://dpcj.org/index.php/dpc/article/view/2824 |
Similar Items
-
Cutaneous immune-related adverse events to immune checkpoint inhibitors: from underlying immunological mechanisms to multi-omics prediction
by: Ting Cao, et al.
Published: (2023-06-01) -
The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study
by: Jade N. Young, BS, et al.
Published: (2024-01-01) -
Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
by: Rui Mao, et al.
Published: (2021-12-01) -
Clinical Observation of Adverse Events of Immune Checkpoint Inhibitors in 20 Advanced Tumor Patients and Literature Reviews
by: WANG Xue, et al.
Published: (2020-06-01) -
Characterizing immune checkpoint inhibitor-related cutaneous adverse reactions: A comprehensive analysis of FDA adverse event reporting system (FAERS) database
by: Buğra Han Esen, et al.
Published: (2024-07-01)